FindTrial
Sign In

Evaluation of Haritaki with and without sharkara(Sugar)as an Anupana (vehicle) on the Bioavailability Enhancer effect of Haritaki (Terminalia chebula Ritz.)

Assessment of comparative Bioavailability of haritaki with and without Sharkara as an Anupana in healthy volunteers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051924
Enrollment
60
Registered
2023-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Mahatma Gandhi Ayurved College Hospital and research centre Salod H Wardha
Lead Sponsor
Dr Dattatray Sarvade
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Liver function tests with normal values Renal Function test with normal values Lipid profile with normal values Blood report within normal limits No history of any major illness and hypertension BMI Index 18.5 to 24.9

Exclusion criteria

Exclusion criteria: Volunteers with any medication or any acute or chronic disease will excluded History of drug or alcohol abuse , liver,kidney ,disorders Hypertension Diabetes BMI index less than 18.5 and more than 24.9

Design outcomes

Primary

MeasureTime frame
To determine the Bioavalability effect of Haritaki with and without sharkara in sharad rituTimepoint: 10 weeks—

Secondary

MeasureTime frame
To determine the Bioavalability effect of Haritaki with and without sharkara in sharad ritu and mimize the dose of drugTimepoint: 8 weeks—

Countries

India

Contacts

Public ContactDr Dattatray Sarvade

Mahatma Gandhi Ayurved College Hospital and Research Centre

dr.sarvade@gmail.com8849334379

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026